Reproductive and Sexual Health Handbook

Borgfeldt C, Andolf E. Transvaginal sonographic ovarian findings in a random sample of women 25-40 years old. Ultrasound Obstet Gynecol. 1999;13(5):345-50.

Royal Australian College of General Practitioners (RACGP). Guidelines for preventive activities in general practice. East Melbourne, Victoria; 2016.

Royal College of Obstetricians and Gynaecologists, The British Society for Gynaecological Endoscopy. Management of Suspected Ovarian Masses in Premenopausal Women. RCOG/BSGE Joint Guideline. Report No.:62. [Internet]. 2011 [updated 2011 Nov 1].

The Royal Australian College of General Practitioners (RACGP). Guidelines for preventive activities in general practice. 9th ed. East Melbourne, Victoria: RACGP; 2018.

Royal College of Obstetricians and Gynaecologists. The Management of Ovarian Cysts in Postmenopausal Women. Report No.: 34 [internet]. 2003 [updated 2016 July]. Available from: https://www.rcog.org.uk/globalassets/documents/guidelines/green-top-guidelines/gtg_34.pdf.

Yeoh M. Investigation and management of an ovarian mass. Aust Fam Physician. 2015;44(1-2):48-52.

Cancer Council Australia. Understanding Ovarian Cancer: A guide for people with cancer, their families and friends. [Internet]. Sydney, NSW: Cancer Council Australia; 2003 [updated 2020 April]. Available from: https://www.cancer.org.au/assets/pdf/understanding-ovarian-cancer-booklet.

Australian Institute of Health and Welfare (AIHW). Cancer data in Australia. Cat no.: CAN 122. [internet]. Australian Government; 2018 [updated 2019 Jul 26]. Available from: https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/contents/summary.

Lux M, Fasching PA, Beckmann MW. Hereditary breast and ovarian cancer: review and future perspectives. J Mol Med (Berl). 2006;84(1):16-28.

Rustin G, Nelstrop AE, Tuxen MK, Lambert HE. Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study. Ann Oncol. 1996;7(4):361-4.

Sagi-Dain L, Lavie O, Auslander R, Sagi S. CA 19-9 in evaluation of adnexal mass: retrospective cohort analysis and review of the literature. Int J Biol Markers. 2015;30(3):e333-40.

Moore R, McKeein DS, Brown AK, DiSilvestro P, Miller MC, Allard WJ, et al. A novel multiple marker bioassay utlizing HE4 and CA 125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol. 2009;112(1):40-6.

Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol. 1990;97(10):922-9.

National Institute for Health and Care Excellence (NICE). Ovarian cancer: recognition and initial management. Report No.:CG122. [internet]. United Kingdom: NICE; 2011. Available from: https://www.nice.org.uk/Guidance/CG122.

Advice about familial aspects of breast cancer and epithelial ovarian cancer: A guide for health providers [internet]. Cancer Australia: Australian Government; 2010 (updated 2015). Available from: https://canceraustralia.gov.au/sites/default/files/publications/advice-about-familial-aspects-breast-cancer-and-epithelial-ovarian-cancer/pdf/2015_bog_familial_aspects_int.pdf.

Neesham D. Ovarian cancer screening. Aust Fam Physician. 2007;36(3):126-8.

Australian Government Cancer Australia. Familial Risk Assessment FRA-BOC [Internet].  Available from: https://canceraustralia.gov.au/clinical-best-practice/gynaecological-cancers/familial-risk-assessment-fra-boc.

Australian Government National Health and Medical Research Council. International evidence-based guideline for the assessment and management of polycystic ovary syndrome. Guidelines. Melbourne, Victoria; 2018.

Illingworth P. How to treat: Infertility. Australian Doctor. 2010;7(May):31-8.

Deeks A, Gibson-Helm ME, Paul E, Teede HJ. Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? Hum Reprod. 2011;26(6):1399-407.

Coffey S, Mason H. The effect of polycystic ovary syndrome on health-related quality of life. Gynecol Endocrinol. 2003;17(5):379-86.

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25.

Lord J, Flight IH, Norman RJ. Metfomin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ. 2003;327(7421):951-3.